BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24701831)

  • 21. [The fusion protein of cytoplasmic transduction peptide (CTP)-HBcAg18-27-Tapasin enhances specific immune response to hepatitis B virus and inhibits viral replication in transgenic mice].
    Tang Y; Chen X; Zhou L; Zhuo M; Zang G; Tang Z; Yu Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):24-9. PubMed ID: 24721239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus.
    Delaney WE; Isom HC
    Hepatology; 1998 Oct; 28(4):1134-46. PubMed ID: 9755254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of hepatitis B virus replication by the internal fragment of hepatitis B core protein.
    Han J; Pan X; Gao Y; Weil L
    Virus Res; 2010 Jun; 150(1-2):129-34. PubMed ID: 20303370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of the G1888A mutation of subgenotype A1 of hepatitis B virus on the translation of the core protein.
    Kimbi GC; Kew MC; Kramvis A
    Virus Res; 2012 Jan; 163(1):334-40. PubMed ID: 22100339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
    Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
    Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection.
    Gong ZJ; De Meyer S; van Pelt J; Hertogs K; Depla E; Soumillion A; Fevery J; Yap SH
    Hepatology; 1999 Feb; 29(2):576-84. PubMed ID: 9918938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of the dependence of hepatitis B virus genotype G on co-infection with other genotypes for viral replication.
    Sakamoto T; Tanaka Y; Watanabe T; Iijima S; Kani S; Sugiyama M; Murakami S; Matsuura K; Kusakabe A; Shinkai N; Sugauchi F; Mizokami M
    J Viral Hepat; 2013 Apr; 20(4):e27-36. PubMed ID: 23490386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PGC1α Transcriptional Adaptor Function Governs Hepatitis B Virus Replication by Controlling HBcAg/p21 Protein-Mediated Capsid Formation.
    Shalaby RE; Iram S; Çakal B; Oropeza CE; McLachlan A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characteristics and functional analysis of full-length hepatitis B virus quasispecies from a patient with chronic hepatitis B virus infection.
    Cui XJ; Cho YK; Song HJ; Choi EK; Kim HU; Song BC
    Virus Res; 2010 Jun; 150(1-2):43-8. PubMed ID: 20184927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human non-hepatocytes support hepadnaviral replication and virion production.
    Galun E; Offensperger WB; von Weizsäcker F; Offensperger S; Wands JR; Blum HE
    J Gen Virol; 1992 Jan; 73 ( Pt 1)():173-8. PubMed ID: 1730939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant Expression of Tandem-HBc Virus-Like Particles (VLPs).
    Stephen SL; Beales L; Peyret H; Roe A; Stonehouse NJ; Rowlands DJ
    Methods Mol Biol; 2018; 1776():97-123. PubMed ID: 29869237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene.
    Günther S; Piwon N; Jung A; Iwanska A; Schmitz H; Will H
    Virology; 2000 Aug; 273(2):286-99. PubMed ID: 10915599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional analysis of HBV genomes from patients with fulminant hepatitis.
    Sterneck M; Kalinina T; Günther S; Fischer L; Santantonio T; Greten H; Will H
    Hepatology; 1998 Nov; 28(5):1390-7. PubMed ID: 9794926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Roles of full-length and truncated hepatitis B virus X protein and of interactions with the host-encoded damaged DNA binding protein 1 in HBV replication].
    Yang X; He S; Luo N; Luo L; Fan H; Gong Q
    Zhonghua Gan Zang Bing Za Zhi; 2013 Jun; 21(6):446-51. PubMed ID: 24034847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B core particle-based anthrax epitope vaccine.
    Yin Y; Zhang S; Cai C; Zhang J; Dong D; Guo Q; Fu L; Xu J; Chen W
    Immunobiology; 2014 Feb; 219(2):97-103. PubMed ID: 24054942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
    Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
    J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quaternary structure is critical for protein display on capsid-like particles (CLPs): efficient generation of hepatitis B virus CLPs presenting monomeric but not dimeric and tetrameric fluorescent proteins.
    Vogel M; Vorreiter J; Nassal M
    Proteins; 2005 Feb; 58(2):478-88. PubMed ID: 15526302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virion Secretion of Hepatitis B Virus Naturally Occurring Core Antigen Variants.
    Shih C; Wu SY; Chou SF; Yuan TT
    Cells; 2020 Dec; 10(1):. PubMed ID: 33396864
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of hepatitis B virus precore/core gene carboxyl terminal mutations on viral biosynthesis and the host immune response.
    Wu JF; Ni YH; Chen HL; Hsu HY; Chang MH
    J Infect Dis; 2014 May; 209(9):1374-81. PubMed ID: 24273041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine inhibition of the hepatitis B virus core promoter.
    Romero R; Lavine JE
    Hepatology; 1996 Jan; 23(1):17-23. PubMed ID: 8550037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.